Healthcare Sector

GSK

Market Tracker

$50.79
+0.89
(+1.78%)
12:00 pm
Next Earnings: (est.) 02/04/17 12:00 am
  • GSK (Selected)

    GlaxoSmithKline plc
  • GSKY

    GreenSky, Inc.

GSK Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

GSK Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

GSK Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

GSK Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

GSK Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

GSK Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
02/20/2026 PUT $50.00 654 +160 +32.39%
01/16/2026 PUT $49.50 51 +35 +218.75%
02/20/2026 CALL $49.00 58 +35 +152.17%
05/15/2026 CALL $46.00 54 +33 +157.14%
01/15/2027 PUT $42.00 606 +30 +5.21%
06/18/2026 CALL $37.00 133 +23 +20.91%
01/16/2026 CALL $46.00 463 -11 -2.32%
06/18/2026 PUT $50.00 235 -11 -4.47%
01/16/2026 CALL $52.00 183 -17 -8.50%
05/15/2026 PUT $50.00 138 -17 -10.97%
01/16/2026 CALL $47.00 3,683 -22 -0.59%
01/16/2026 CALL $49.00 240 -46 -16.08%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

GSK Major Holders

Name Pct Held Shares Total
Dodge & Cox Stock Fund 2.22% 45.46M 1.57B
Dodge & Cox Balanced Fund 0.29% 5.99M 206.79M
Price (T.Rowe) International Value Equity Fund 0.16% 3.28M 113.2M
Vanguard/Primecap Fund 0.15% 3.01M 103.97M
Price (T.Rowe) International Value Equity Trust 0.14% 2.86M 98.7M
Fidelity Series Large Cap Stock Fund 0.14% 2.84M 97.98M
Price (T.Rowe) Overseas Stock Fund 0.13% 2.64M 91.02M
American Mutual Fund Inc 0.08% 1.74M 59.98M
Fidelity Growth & Income Portfolio 0.08% 1.6M 55.17M
Vanguard/Windsor II 0.08% 1.57M 54.09M

GSK News

  • Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

    01/13 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary

    01/08 07:00 pm

    GlobeNewswire Inc.

    Read more
  • GSK/Ionis Partnered Investigational Drug Shows Strong Results In Large Hepatitis B Studies

    01/07 12:48 pm

    Benzinga

    Read more
  • Sitryx to attend J.P. Morgan Healthcare Conference 2026 showcasing pipeline of novel small molecule candidates targeting major autoimmune indications

    01/06 08:00 am

    GlobeNewswire Inc.

    Read more
  • Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026

    12/31 09:59 am

    Benzinga

    Read more
  • Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out

    12/19 01:43 pm

    Benzinga

    Read more
  • FDA Approves GSK's Drug, Targets Severe Asthma With Two Doses Per Year

    12/17 10:04 am

    Benzinga

    Read more
  • GSK Expands Use Of Urinary Tract Infection Drug For Gonorrhoea Patients

    12/12 12:12 pm

    Benzinga

    Read more
  • Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer

    12/10 03:00 am

    GlobeNewswire Inc.

    Read more
  • AstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report

    12/03 01:24 pm

    Benzinga

    Read more
  • Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    11/28 09:00 am

    GlobeNewswire Inc.

    Read more
  • Asthma and COPD Medicines Market Size to Lead USD 19.32 Bn by 2035

    11/26 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight

    11/24 02:00 pm

    GlobeNewswire Inc.

    Read more
  • GSK Unit Tesaro Sues AnaptysBio, Threatening Key Cancer Drug Jemperli Royalties

    11/21 09:48 am

    Benzinga

    Read more
  • Anaptys Initiates Litigation Against Tesaro, a GSK Subsidiary

    11/21 04:50 am

    GlobeNewswire Inc.

    Read more
  • SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK

    11/19 08:00 am

    GlobeNewswire Inc.

    Read more
  • IMU Biosciences announces formation of Scientific Advisory Board

    11/13 04:00 am

    GlobeNewswire Inc.

    Read more
  • Nutraceutical Ingredients Market Size Worth USD 191.04 Bn by 2034

    11/07 03:22 am

    GlobeNewswire Inc.

    Read more
  • Anti-Inflammatory Drugs Market to Reach USD 274.79 Billion by 2034, Fueled by Rising Innovation and Accessibility

    10/31 11:00 am

    GlobeNewswire Inc.

    Read more
  • GSK Upgrades 2025 Financial Outlook, CEO Says Positioned Well For 2026

    10/29 09:08 am

    Benzinga

    Read more
  • New Global Coalition Launches to Address the Hidden Threat of RSV in Adults

    10/26 03:17 pm

    GlobeNewswire Inc.

    Read more
  • Human Combinatorial Antibody Libraries Market to Surge USD 189.57 Million by 2034, Reports Towards Healthcare

    10/24 11:00 am

    GlobeNewswire Inc.

    Read more
  • FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep

    10/24 10:23 am

    Benzinga

    Read more
  • Alector Announces Results from its Phase 3 Clinical Trial of Potential FTD-GRN Therapeutic

    10/21 06:45 pm

    GlobeNewswire Inc.

    Read more
  • UK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment

    10/17 12:43 pm

    Benzinga

    Read more
  • Chairman and CEO of Zenas BioPharma (ZBIO) Buys 36,928 Shares for $769,948

    10/16 12:12 pm

    The Motley Fool

    Read more
  • Molecule Therapeutics Market Size, Companies and Emerging Technologies Insight – Towards Healthcare

    10/10 09:00 am

    GlobeNewswire Inc.

    Read more
  • Top Technology Executives Recognized at the 2025 BayAreaCIO ORBIE Awards

    09/26 03:50 pm

    GlobeNewswire Inc.

    Read more
  • Trump’s Tariff Gambit: Pharma in the Crosshairs and Global Markets on Edge

    09/26 02:54 am

    Investing.com

    Read more
  • Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'

    09/26 12:08 am

    Benzinga

    Read more
  • Influenza Vaccine Market Size to Cross USD 16.73 billion by 2034 at 7.02% CAGR

    09/25 11:00 am

    GlobeNewswire Inc.

    Read more
  • Pneumococcal Vaccine Market Opportunities and Strategies to 2034 - Pediatric Segment Holds the Major Opportunity in Market Expansion

    09/24 12:48 pm

    GlobeNewswire Inc.

    Read more
  • New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies

    09/24 02:30 am

    GlobeNewswire Inc.

    Read more
  • Maternal Mental Health Market to Worth USD 126.33 Billion Rising at 28.47% CAGR by 2034

    09/19 10:00 am

    GlobeNewswire Inc.

    Read more
  • GSK To Pour $30 Billion Into US R&D, Manufacturing Over Five Years

    09/17 10:06 am

    Benzinga

    Read more
  • Software Automation in Research and Development (R&D) Clinical Trials Training Course | Harnessing Automation Technology to Deliver Faster, Cost-Effective Outcomes (Oct 1, 2025)

    09/04 10:00 am

    GlobeNewswire Inc.

    Read more
  • Acne Medicine Market Size Projected to Reach USD 23.33 Billion by 2034

    09/01 10:00 am

    GlobeNewswire Inc.

    Read more
  • Questex’s Fierce Pharma Week Announces Star-Studded Lineup with Jamie-Lynn Sigler, James Van Der Beek, Selma Blair, Kelly Killoran Bensimon and John Duffield to Provide Powerful Stories of Resilience and Healing

    08/20 10:00 am

    GlobeNewswire Inc.

    Read more
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK

    08/17 11:34 am

    GlobeNewswire Inc.

    Read more
  • 24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025

    08/14 09:06 pm

    GlobeNewswire Inc.

    Read more
  • Global Cancer Vaccines Market to Surpass USD 15.00 Billion by 2032, Unlocking Over USD 10 Billion in New Growth Opportunities | MarketsandMarkets™.

    08/11 09:00 am

    GlobeNewswire Inc.

    Read more
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK

    08/09 11:57 am

    GlobeNewswire Inc.

    Read more
  • Dynavax (DVAX) Q2 Revenue Jumps 29%

    08/07 05:25 pm

    The Motley Fool

    Read more
  • Global Myeloproliferative Disorder Treatment Market is Expected to Showcase an Incremental Growth at a CAGR of ~5% by 2032 | DelveInsight

    08/06 01:00 pm

    GlobeNewswire Inc.

    Read more
  • ITRM Reports Results

    08/05 10:22 pm

    The Motley Fool

    Read more
  • IDEAYA (IDYA) Q2 Net Loss Improves 27%

    08/05 04:23 pm

    The Motley Fool

    Read more
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK

    08/05 10:00 am

    GlobeNewswire Inc.

    Read more
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK

    08/01 10:00 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: